JPRN-UMIN000008863
Completed
未知
Evaluation of the usefulness of anti-cholinergic and B(Beta)3 agonist in patients with OAB. - Search of the clinical efficacy and safety for the Overactive bladder patients Received by imidafenacin and mirabegron as Therapeutic agents (SORT Study)
Clinical Research Support Center Kyushu0 sites400 target enrollmentOctober 1, 2012
ConditionsOveractive bladder
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Overactive bladder
- Sponsor
- Clinical Research Support Center Kyushu
- Enrollment
- 400
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients who has contraindication of Imidafenacin 2\)Patients who has contraindication of Mirabegron 3\)Patients with urinary flow decreased 4\)Patients with history of urinary retention 5\)Patients with arrhythmia 6\)Patients with hypokalemia 7\)Patients with serious kidney dysfunction 8\)Residual urine volume is more than 100mL 9\)Patients with bladder cancer, urinary tract stones, symptomatic urinary tract infection, recurrent urinary tract infection and interstitial cystitis. 10\)Patients with polyuria 11\)Patients who have administered prohibited substances or done prohibited therapy within the 4 weeks before enrollment 12\)Patients who have a urology or genital surgery within the 6 months before enrollment 13\)Patients with history of resistance to anti\-holinergic agents 14\)Lower urinary tract symptoms aren't stable. 15\)Any other patients who are regarded as unsuitable for this study by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study on the safety and efficacy of anticolinergics for children with overactive bladderPediatric overactive bladderJPRN-UMIN000017267Department of Renal and Urologic Surgery, Asahikawa Medical University150
Active, not recruiting
Phase 1
Impact of anticholinergic treatment on urinary discomfort during radiotherapy for prostate cancerSymptomatology related to acute urinary toxicity occuring during prostate irradiation in patients suffering from prostate cancer.MedDRA version: 18.1Level: HLTClassification code 10004995Term: Bladder and urethral symptomsSystem Organ Class: 100000004857Therapeutic area: Diseases [C] - Male diseases of the urinary and reproductive systems [C12]EUCTR2014-004296-22-FRCentre Eugène Marquis
Completed
Not Applicable
Global Assessment Study of Anti-cholinergics on Efficacy and Tolerability for Patients with OABJPRN-UMIN000003033GAP Study Group300
Completed
Not Applicable
A study of the effect of long-term anticholinergic administration -solifenacin succinateoveractive bladderJPRN-UMIN000017260Hokkaido University Graduate School of Medicine100
Not yet recruiting
Not Applicable
Evaluation of clinical effectiveness of choline alphoscerate for older adults with major depressioMental and behavioural disordersKCT0007062Samsung Medical Center120